References
Jacobson AM, Ryan CM, Cleary PA et al (2011) Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the diabetes control and complications trial (DCCT) cohort. Diabetologia 54(2):245–255
Jacobson AM, Ryan CM, Braffett BH et al (2021) Cognitive performance declines in older adults with type 1 diabetes: results from 32 years of follow-up in the DCCT and EDIC Study. Lancet Diabetes Endocrinol 9(7):436–445
Tam CS, Xie W, Johnson WD et al (2012) Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care 35(7):1605–1610
Blazquez E, Velazquez E, Hurtado-Carneiro V, Ruiz-Albusac JM (2014) Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer’s disease. Front Endocrinol (Lausanne) 5:161
Samaras K, Makkar S, Crawford JD et al (2020) Metformin use is associated with slowed cognitive decline and reduced incident dementia in older adults with type 2 diabetes: the sydney memory and ageing study. Diabetes Care 43(11):2691–2701
Acknowledgments
The Diabetes Control and Complications Trial (DCCT) and its follow-up the Epidemiology of Diabetes Interventions and Complications (EDIC) study were conducted by the DCCT/EDIC Research Group and supported by National Institute of Health grants and contracts and by the General Clinical Research Center Program, NCRR. The data from the DCCT/EDIC study were supplied by the NIDDK Central Repositories. This manuscript was not prepared under the auspices of the DCCT/EDIC study and does not represent analyses or conclusions of the DCCT/EDIC study group, the NIDDK Central Repositories, or the NIH.
Author information
Authors and Affiliations
Contributions
Y.M. designed the study, conduct data analysis, and wrote the manuscript. W.Z. conduct data analysis and wrote results.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All studies were conducted in accordance with principles for human experimentation as defined in the Declaration of Helsinki, and approved by the relevant institutional review boards.
Informed consent
Informed consent is not applicable.
Additional information
Managed by Massimo Porta.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Mao, Y., Zhong, W. Insulin resistance is associated with cognitive decline in type 1 diabetes mellitus. Acta Diabetol 59, 571–573 (2022). https://doi.org/10.1007/s00592-021-01846-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-021-01846-z